NASDAQ : SLS

SELLAS Life Sciences Group, Inc. — Earnings Estimates

$10.835 USD

-$0.48 (-4.28%)

Volume
9.09M
Average Volume
9.46M
Market Capitalization
$2.02B
P/E Ratio
-47.46
Dividend Yield
0.00%
Price Target
$25.00
Year High
$15.88
Year Low
$1.39
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$17.22

Annual earnings financials

SLS financial data with annual/quarterly toggle

SLS GAAP EPS - Annual & Quarterly

SLS Sales Revenue - Annual & Quarterly

SLS Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

SLS Estimated and Actual Revenue by Quarter
SLS Estimated and Actual EPS by Quarter
SLS Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-31 1 7.23M 7.23M 7.23M 7.23M 7.23M 7.23M
2026-09-30 0 - - - - - -
2026-06-30 0 - - - - - -
2026-03-31 0 - - - - - -
2025-12-31 0 - - - - - -
2025-09-30 0 - - - - - -
SLS Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-31 1 -9.49M -9.49M -9.49M 123.37M 123.37M 123.37M
2026-09-30 0 -10.35M -8.62M -9.49M - - -
2026-06-30 0 -8.62M -6.9M -7.76M - - -
2026-03-31 0 -13.8M -6.9M -10.35M - - -
2025-12-31 0 -13.78M -7.66M -9.7M - - -
2025-09-30 0 -10.84M -6.5M -8.31M - - -
SLS Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-31 1 36.13M 36.13M 36.13M 1 -0.055 -0.055 -0.055
2026-09-30 0 - - - 2 -0.06 -0.05 -0.055
2026-06-30 0 - - - 2 -0.05 -0.04 -0.045
2026-03-31 0 - - - 2 -0.08 -0.04 -0.06
2025-12-31 0 - - - 3 -0.09000426 -0.05000237 -0.063333
2025-09-30 0 - - - 3 -0.09999609 -0.05999765 -0.076667